Park M - Search Results

1

Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea.

Carman RJ, Genheimer CW, Rafii F, Park M, Hiltonsmith MF, Lyerly DM. Carman RJ, et al. Among authors: park m. Anaerobe. 2009 Dec;15(6):244-8. doi: 10.1016/j.anaerobe.2009.09.009. Epub 2009 Oct 8. Anaerobe. 2009. PMID: 19818865

2

Characterization of an ATP-binding cassette from Clostridium perfringens with homology to an ABC transporter from Clostridium hathewayi.

Rafii F, Park M, Carman RJ. Rafii F, et al. Among authors: park m. Anaerobe. 2009 Aug;15(4):116-21. doi: 10.1016/j.anaerobe.2009.01.008. Anaerobe. 2009. PMID: 19655423

3

Effects of gyrase mutation on the growth kinetics of ciprofloxacin-resistant strains of Clostridium perfringens.

Rafii F, Park M. Rafii F, et al. Among authors: park m. Anaerobe. 2005 Aug;11(4):201-5. doi: 10.1016/j.anaerobe.2005.01.004. Epub 2005 Mar 3. Anaerobe. 2005. PMID: 16701569

4

Substitutions of amino acids in alpha-helix-4 of gyrase A confer fluoroquinolone resistance on Clostridium perfringens.

Rafii F, Park M. Rafii F, et al. Among authors: park m. Arch Microbiol. 2007 Feb;187(2):137-44. doi: 10.1007/s00203-006-0180-y. Epub 2006 Oct 19. Arch Microbiol. 2007. PMID: 17051403

5

Exposure to β-lactams results in the alteration of penicillin-binding proteins in Clostridium perfringens.

Park M, Rafii F. Park M, et al. Anaerobe. 2017 Jun;45:78-85. doi: 10.1016/j.anaerobe.2017.02.004. Epub 2017 Feb 7. Anaerobe. 2017. PMID: 28185856

6

The prevalence of plasmid-coded cpe enterotoxin, β₂ toxin, tpeL toxin, and tetracycline resistance in Clostridium perfringens strains isolated from different sources.

Park M, Rafii F. Park M, et al. Anaerobe. 2019 Apr;56:124-129. doi: 10.1016/j.anaerobe.2019.02.007. Epub 2019 Feb 22. Anaerobe. 2019. PMID: 30802555

7

β-Lactam resistance development affects binding of penicillin-binding proteins (PBPs) of Clostridium perfringens to the fluorescent penicillin, BOCILLIN FL.

Park M, Sutherland JB, Rafii F. Park M, et al. Anaerobe. 2020 Apr;62:102179. doi: 10.1016/j.anaerobe.2020.102179. Epub 2020 Feb 20. Anaerobe. 2020. PMID: 32088319

8

Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones.

Rafii F, Park M, Novak JS. Rafii F, et al. Among authors: park m. Antimicrob Agents Chemother. 2005 Feb;49(2):488-92. doi: 10.1128/AAC.49.2.488-492.2005. Antimicrob Agents Chemother. 2005. PMID: 15673722 Free PMC article.

9

Comparative transcription analysis and toxin production of two fluoroquinolone-resistant mutants of Clostridium perfringens.

Park S, Park M, Rafii F. Park S, et al. Among authors: park m. BMC Microbiol. 2013 Mar 1;13:50. doi: 10.1186/1471-2180-13-50. BMC Microbiol. 2013. PMID: 23452396 Free PMC article.

10

Effect of fluoroquinolone resistance selection on the fitness of three strains of Clostridium perfringens.

Park M, Sutherland JB, Kim JN, Rafii F. Park M, et al. Microb Drug Resist. 2013 Dec;19(6):421-7. doi: 10.1089/mdr.2013.0056. Epub 2013 Jun 21. Microb Drug Resist. 2013. PMID: 23789809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,611 results

Search Page

Filters